Efficient synthesis of optically active 4,5-dihydroxy-2,3,4,5-tetrahydro-1H-1-benzazepine derivatives utilizing lipase-catalyzed transesterification

被引:2
作者
Ohtani, Tadaaki
Kitano, Kazuyoshi
Matsubara, Jun
Kawano, Yoshikazu
Komatsu, Makoto
Uchida, Minoru
Tabusa, Fujio
Nagao, Yoshimitsu
机构
[1] Otsuka Pharmaceut Co Ltd, Med Chem Res Inst, Tokushima 7710192, Japan
[2] Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima 7708505, Japan
关键词
kinetic resolution; isomerization; Mitsunobu esterification; dechlorination; lipase-catalyzed transesterification;
D O I
10.3987/COM-06-S(O)42
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
As an efficient and enantioselective synthesis of the 4,5-dihydroxybenzazepine compounds, the syntheses of optically active 5-O-protected trans4,5-dihydroxybenzazepine derivatives were accomplished. The trans-7-chloro4-hydroxy-5-methoxymethoxy-1-(p-toluenesulfonyl)-2,3,4,5-tetrahydro-IH-1- benzazepine [(+/-)-4] was kinetically resolved by lipase-catalyzed transesterification. The optically active 4* was isomerized into the cis compound (6*) utilizing the Mitsunobu esterification followed by hydrolysis. The chiral compounds (4* and 6*) were converted to the 4,5-bismethoxymethoxy compounds (7*-10*), which were the intermediates for the compounds (2a, b and 3a, b).
引用
收藏
页码:333 / +
页数:19
相关论文
共 8 条
[1]   QUANTITATIVE-ANALYSES OF BIOCHEMICAL KINETIC RESOLUTIONS OF ENANTIOMERS [J].
CHEN, CS ;
FUJIMOTO, Y ;
GIRDAUKAS, G ;
SIH, CJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1982, 104 (25) :7294-7299
[2]   An efficient synthesis of optically active metabolites of platelet adhesion inhibitor OPC-29030 by lipase-catalyzed enantioselective transesterification [J].
Kitano, K ;
Matsubara, J ;
Ohtani, T ;
Otsubo, K ;
Kawano, Y ;
Morita, S ;
Uchida, M .
TETRAHEDRON LETTERS, 1999, 40 (28) :5235-5238
[3]   7-chloro-5-hydroxy-1-[2-methyl-4-(2-metaminobenzoyl]-amino)benzoyl]-2,3,4,5-5-tetrahydro-1H-1-benzazepine (OPC-41061):: A potent, orally active nonpeptide arginine vasopressin V2 receptor antagonist [J].
Kondo, K ;
Ogawa, H ;
Yamashita, H ;
Miyamoto, H ;
Tanaka, M ;
Nakaya, K ;
Kitano, K ;
Yamamura, Y ;
Nakamura, S ;
Onogawa, T ;
Mori, T ;
Tominaga, M .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (08) :1743-1754
[4]   Enantioselective synthesis of the metabolites of vasopressin V2 receptor antagonist OPC-31260 via lipase-catalyzed transesterification [J].
Matsubara, J ;
Kitano, K ;
Otsubo, K ;
Kawano, Y ;
Ohtani, T ;
Bando, M ;
Kido, M ;
Uchida, M ;
Tabusa, F .
TETRAHEDRON, 2000, 56 (27) :4667-4682
[5]   An efficient synthesis of optical isomers of vasopressin V2 receptor antagonist OPC-41061 by lipase-catalyzed enantioselective transesterification [J].
Matsubara, J ;
Morita, S ;
Yamashita, H ;
Otsubo, K ;
Kitano, K ;
Ohtani, T ;
Kawano, Y ;
Bando, M ;
Kido, M ;
Uchida, M ;
Tabusa, F .
HETEROCYCLES, 2001, 54 (01) :131-138
[6]   Synthesis of a key intermediate, (S)-2-[(3-hydroxypropyl)sulfinyl]-1-(o-tolyl)imidazole, for the platelet aggregation inhibitor, OPC-29030 via lipase-catalyzed enantioselective transesterification [J].
Morita, S ;
Matsubara, J ;
Otsubo, K ;
Kitano, K ;
Ohtani, T ;
Kawano, Y ;
Uchida, M .
TETRAHEDRON-ASYMMETRY, 1997, 8 (22) :3707-3710
[7]   An efficient synthesis of a key intermediate for vasopressin V2 receptor agonist OPC-51803 by lipase-catalyzed enantioselective transesterification [J].
Ohtani, T ;
Kitano, K ;
Matsubara, J ;
Morita, S ;
Kawano, Y ;
Komatsu, M ;
Bando, M ;
Kido, M ;
Uchida, M ;
Tabusa, F .
HETEROCYCLES, 2002, 58 :635-643
[8]   CHARACTERIZATION OF A NOVEL AQUARETIC AGENT, OPC-31260, AS AN ORALLY EFFECTIVE, NONPEPTIDE VASOPRESSIN V2-RECEPTOR ANTAGONIST [J].
YAMAMURA, Y ;
OGAWA, H ;
YAMASHITA, H ;
CHIHARA, T ;
MIYAMOTO, H ;
NAKAMURA, S ;
ONOGAWA, T ;
YAMASHITA, T ;
HOSOKAWA, T ;
MORI, T ;
TOMINAGA, M ;
YABUUCHI, Y .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (04) :787-791